QL
ZNTL icon

Quarry LP’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Quarry LP’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Sell
125,114
-24,886
-17% -$99.4K 0.05% 129
2026
Q1 		$351K Buy
150,000
+18,000
+14% +$46.5K 0.06% 212
2025
Q4 		$178K Buy
132,000
+23,250
+21% +$33.8K 0.03% 290
2025
Q3 		$164K Buy
108,750
+3,750
+4% +$5.62K 0.04% 404
2025
Q2 		$122K Sell
105,000
-15,000
-13% -$19.8K 0.03% 480
2025
Q1 		$191K Buy
120,000
+66,500
+124% +$143K 0.04% 312
2024
Q4 		$162K Buy
53,500
+38,500
+257% +$126K 0.02% 297
2024
Q3 		$55.2K Buy
+15,000
New +$54.5K 0.01% 682

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Quarry LP's ZNTL Position: Q2 2026 in Review

Quarry LP reduced its Zentalis Pharmaceuticals (ZNTL) stake by 17% in Q2 2026, selling an estimated $99.4K and leaving 125,114 shares worth $607K. The position accounts for 0.05% of the portfolio, ranked #129.

Quarry LP first reported a position in ZNTL in Q3 2024 and has held it in 8 quarters since. 114 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

  • Quarry LP held 125,114 shares of Zentalis Pharmaceuticals worth $607K as of Q2 2026.
  • Quarry LP sold 24,886 Zentalis Pharmaceuticals shares in Q2 2026, an estimated $99.4K.
  • Zentalis Pharmaceuticals made up 0.05% of Quarry LP's portfolio in Q2 2026, its #129 holding.
  • Quarry LP first reported a position in Zentalis Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 114 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.